StocksFundsScreenerSectorsWatchlists
INGN

INGN - Inogen Inc Stock Price, Fair Value and News

8.12USD+0.15 (+1.88%)Delayed as of 28 Mar 2024, 11:54 am ET

Market Summary

INGN
USD8.12+0.15
Delayedas of 28 Mar 2024, 11:54 am
1.88%

INGN Stock Price

View Fullscreen

INGN RSI Chart

INGN Valuation

Market Cap

185.9M

Price/Earnings (Trailing)

-1.81

Price/Sales (Trailing)

0.59

EV/EBITDA

-0.72

Price/Free Cashflow

-22

INGN Price/Sales (Trailing)

INGN Profitability

Operating Margin

40.14%

EBT Margin

-32.42%

Return on Equity

-50.02%

Return on Assets

-31.41%

Free Cashflow Yield

-4.55%

INGN Fundamentals

INGN Revenue

Revenue (TTM)

315.7M

Rev. Growth (Yr)

-13.84%

Rev. Growth (Qtr)

-9.61%

INGN Earnings

Earnings (TTM)

-102.4M

Earnings Growth (Yr)

53.09%

Earnings Growth (Qtr)

41.92%

Breaking Down INGN Revenue

52 Week Range

4.7914.10
(Low)(High)

Last 7 days

2.5%

Last 30 days

-29.5%

Last 90 days

22.3%

Trailing 12 Months

-48.8%

How does INGN drawdown profile look like?

INGN Financial Health

Current Ratio

2.86

Debt/Equity

4e-4

Debt/Cashflow

-40.42

INGN Investor Care

Shares Dilution (1Y)

1.56%

Diluted EPS (TTM)

-4.42

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023369.0M349.3M327.9M315.7M
2022351.5M353.3M365.6M377.2M
2021306.9M336.8M355.6M358.0M
2020360.2M330.9M313.4M308.5M
2019369.3M373.1M369.6M361.9M
2018276.0M309.1M335.4M358.1M
2017212.3M221.9M236.5M249.4M
2016168.2M178.8M192.4M202.8M
2015122.7M136.3M147.7M159.0M
201483.3M93.6M103.2M112.5M
201355.3M62.0M68.7M75.4M
201200048.6M
200900010.7M

Tracking the Latest Insider Buys and Sells of Inogen Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 01, 2024
glezer stanislav
sold (taxes)
-53,551
7.025
-7,623
evp, r&d & chief med. officer
Mar 01, 2024
somer jason
sold (taxes)
-32,146
7.025
-4,576
evp, gen. counsel & secretary
Mar 01, 2024
somer jason
acquired
-
-
7,150
evp, gen. counsel & secretary
Mar 01, 2024
glezer stanislav
acquired
-
-
13,914
evp, r&d & chief med. officer
Dec 01, 2023
glezer stanislav
sold (taxes)
-13,333
5.72
-2,331
evp, chief technology officer
Dec 01, 2023
glezer stanislav
acquired
-
-
4,555
evp, chief technology officer
Dec 01, 2023
somer jason
sold (taxes)
-1,635
5.72
-286
evp, gen. counsel & secretary
Dec 01, 2023
somer jason
acquired
-
-
576
evp, gen. counsel & secretary
Sep 01, 2023
somer jason
acquired
-
-
577
evp, gen. counsel & secretary
Sep 01, 2023
shabshab nabil
sold (taxes)
-12,001
6.18
-1,942
ceo and president

1–10 of 50

Which funds bought or sold INGN recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
added
2,918
42,047
43,415
-%
Mar 11, 2024
VANGUARD GROUP INC
added
0.39
394,335
7,455,820
-%
Mar 04, 2024
TUCKER ASSET MANAGEMENT LLC
sold off
-100
-10.00
-
-%
Mar 01, 2024
GOLDMAN SACHS GROUP INC
added
129
994,366
1,696,080
-%
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-0.4
2,882
63,596
-%
Feb 26, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
sold off
-100
-4,000
-
-%
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
reduced
-7.61
-4,000
125,000
-%
Feb 16, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
unchanged
-
9,988
195,988
-%
Feb 15, 2024
BARCLAYS PLC
added
58.69
171,000
428,000
-%
Feb 15, 2024
Tidal Investments LLC
added
2.08
6,958
101,450
-%

1–10 of 49

Are Funds Buying or Selling INGN?

Are funds buying INGN calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own INGN
No. of Funds

Unveiling Inogen Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
camber capital management lp
8.58%
2,013
SC 13G/A
Feb 14, 2024
brown capital management llc
6.69%
1,560,409
SC 13G/A
Feb 13, 2024
vanguard group inc
5.83%
1,358,072
SC 13G/A
Jan 24, 2024
blackrock inc.
9.6%
2,240,324
SC 13G/A
Jul 24, 2023
camber capital management lp
6.92%
2,013
SC 13G
Jul 10, 2023
vanguard group inc
6.40%
1,480,064
SC 13G/A
Jul 07, 2023
blackrock inc.
7.5%
1,729,549
SC 13G/A
Feb 14, 2023
brown capital management llc
7.48%
1,715,188
SC 13G/A
Feb 09, 2023
vanguard group inc
11.76%
2,694,460
SC 13G/A
Feb 01, 2023
blackrock inc.
17.5%
4,009,764
SC 13G/A

Recent SEC filings of Inogen Inc

View All Filings
Date Filed Form Type Document
Mar 06, 2024
4
Insider Trading
Mar 06, 2024
3
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 05, 2024
4
Insider Trading
Mar 01, 2024
S-8
Employee Benefits Plan
Mar 01, 2024
S-8
Employee Benefits Plan
Mar 01, 2024
10-K
Annual Report
Feb 27, 2024
8-K
Current Report
Feb 14, 2024
SC 13G/A
Major Ownership Report

Peers (Alternatives to Inogen Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
196.9B
40.1B
-3.02% 19.11%
34.4
4.91
-8.12% -17.45%
71.2B
19.5B
2.28% 4.53%
56.69
3.65
4.02% -22.04%
24.6B
3.9B
3.45% 0.50%
55.33
6.38
3.42% 23.09%
21.7B
14.8B
1.75% 11.60%
8.16
1.46
2.12% 209.17%
MID-CAP
10.2B
2.7B
2.92% -30.26%
-16.04
3.83
-4.68% 82.43%
9.7B
12.3B
-3.34% -3.19%
23.21
0.78
-2.44% -22.68%
9.5B
3.5B
2.97% 25.27%
33.57
2.74
4.97% 18.89%
6.9B
4.0B
-2.47% -11.08%
-51.36
1.74
1.10% 85.84%
3.5B
366.4M
0.74% 28.92%
-577.22
9.59
33.86% 89.80%
2.5B
6.6B
-3.84% 3.03%
12.86
0.38
2.78% -0.87%
SMALL-CAP
1.5B
3.2B
47.53% -25.51%
-2.23
0.47
7.73% -1066.14%
379.3M
166.7M
5.16% -2.53%
-4.59
2.28
6.67% -456.34%
227.2M
329.5M
-13.41% -54.45%
-16.09
0.69
0.49% 64.22%
43.3M
52.3M
-46.12% -38.06%
-2.31
0.83
17.61% 19.28%
4.5M
3.7M
2.40% 338.46%
-0.37
1.19
5.77% 8.23%

Inogen Inc News

Latest updates
Zacks Investment Research • 70 minutes ago
MarketBeat • 20 Mar 2024 • 07:00 am
Defense World • 11 Mar 2024 • 07:00 am
Business Wire • 07 Mar 2024 • 09:00 pm
Yahoo Finance • 23 Feb 2024 • 08:00 am
InvestorsObserver • 31 Jan 2024 • 08:00 am

Inogen Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue-9.6%75,896,00083,967,00083,635,00072,162,00088,091,000105,389,000103,376,00080,385,00076,403,00093,105,000101,563,00086,932,00073,978,00074,329,00071,691,00088,489,00078,917,00091,761,000101,063,00090,202,00086,531,000
Cost Of Revenue-4.9%47,738,00050,203,00049,591,00041,429,00058,620,00062,591,00057,118,00045,379,00037,815,00045,418,00051,228,00047,059,00039,919,00041,323,00038,942,00050,123,00044,995,00048,446,00050,848,00045,793,00042,961,000
Gross Profit-16.6%28,158,00033,764,00034,044,00030,733,00029,471,00042,798,00046,258,00035,006,00038,588,00047,687,00050,335,00039,873,00034,059,00033,006,00032,749,00038,366,00033,922,00043,315,00050,215,00044,409,00043,570,000
Operating Expenses-29.0%57,140,00080,485,00045,812,00052,648,00087,960,00053,090,00049,134,00048,592,00045,261,00041,313,00038,664,00042,005,00039,581,00034,979,00035,100,00040,545,00039,243,00035,208,00038,070,00039,551,00038,795,000
  S&GA Expenses-1.7%25,653,00026,091,00026,906,00028,441,00028,606,00033,734,00030,388,00028,039,00029,706,00028,301,00029,317,00025,491,00025,389,00022,882,00022,086,00027,163,00025,544,00024,047,00027,758,00028,201,00028,265,000
  R&D Expenses49.6%6,714,0004,489,0004,293,0005,344,0005,934,0004,581,0006,064,0005,364,0004,684,0003,754,0004,123,0004,015,0003,674,0003,511,0003,290,0003,605,0003,628,0002,636,0001,468,0001,669,0001,742,000
EBITDA Margin22.4%-0.27-0.34-0.22-0.18-0.16-0.030.010.060.080.090.070.04---------
Income Taxes-232.9%-533,000401,00041,000196,000141,00070,00069,000224,00015,988,000-6,245,0006,902,000-1,653,000-84,000-214,000945,000-98,000-2,862,0001,890,0003,524,000770,000-4,222,000
Earnings Before Taxes40.2%-27,088,000-45,318,000-9,785,000-20,153,000-56,469,000-9,436,000-3,373,000-13,990,000-6,889,0005,929,00012,004,000-2,385,000-5,205,000-1,913,0003,525,000-1,687,000-4,237,0008,753,00013,684,0006,072,0005,823,000
EBT Margin19.3%-0.32-0.40-0.27-0.24-0.22-0.09-0.05-0.010.020.030.01-0.02---------
Net Income41.9%-26,555,000-45,719,000-9,826,000-20,349,000-56,610,000-9,506,000-3,442,000-14,214,000-22,877,00012,174,0005,102,000-732,000-5,121,000-1,699,0002,580,000-1,589,000-1,375,0006,863,00010,160,0005,302,00010,045,000
Net Income Margin19.7%-0.32-0.40-0.28-0.24-0.22-0.14-0.08-0.06-0.020.03-0.01-0.02---------
Free Cashflow-407.5%-4,542,0001,477,0001,990,000-7,377,000-16,049,000-10,017,0004,661,000-19,464,0005,823,000-4,207,00015,191,0001,344,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-5.1%326344374386405470470475490513498476462460458459447445404388376
  Current Assets-8.1%207225269283305318315318329336328310306303303303292290341322315
    Cash Equivalents0.7%125125168164187210224213236242239220212214214208198156214190197
  Inventory-9.1%22.0024.0031.0039.0034.0036.0033.0034.0032.0032.0027.0026.0025.0029.0036.0038.0036.0034.0024.0029.0027.00
  Net PPE1.6%50.0050.0049.0046.0043.0041.0040.0039.0039.0037.0034.0031.0028.0025.0022.0020.0019.0020.0021.0022.0022.00
  Goodwill1.9%10.0010.0033.0033.0033.0033.0033.0033.0033.0033.0033.0033.0033.0033.0033.0033.0033.0033.002.002.002.00
Liabilities7.4%12111310010410811911411611912212712011210810711210310270.0066.0065.00
  Current Liabilities20.1%72.0060.0059.0063.0065.0066.0059.0060.0062.0060.0062.0055.0057.0052.0051.0056.0050.0050.0046.0044.0047.00
Shareholder's Equity-11.2%205231275281297351357358370391371356350353351347345343334322310
  Retained Earnings-29.4%-116-90.39-44.67-34.85-14.5042.0052.0055.0069.0092.0080.0075.0076.0081.0082.0080.0081.0083.0076.0066.0060.00
  Additional Paid-In Capital-0.3%321322319316312309305302299297290280274271268267263260257255249
Accumulated Depreciation-----52.0051.0051.0051.0052.0050.0049.0047.0046.0045.0045.0046.0045.0044.0043.0043.0042.00
Shares Outstanding0.1%23.0023.0023.0023.0023.0023.0023.0023.0023.0023.0022.0022.00---------
Float-------311---853---406---811--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations-244.1%-3,1482,1854,030-6,301-15,482-9,4835,531-18,0986,498-2,99417,2692,86016,1986,74513,5305409,38914,60118,427-1,82412,337
  Share Based Compensation-159.4%-1,0571,7793,2633,4423,0983,5003,0202,6652,3962,7923,2392,5162,0922,0501,2772,7842,1991,5651,7793,5863,007
Cashflow From Investing109.0%4,128-45,793-540-17,110-6,944-4,7554,874-4,052-12,3771,154-4,408986-18,522-7,969-8,0488,89931,452-73,6775,116-6,9482,000
Cashflow From Financing-103.1%-14.00448-33.00559-112701-101-108-30.004,6905,9134,42784.0094661.009759821,3291722,4466,087

INGN Income Statement

2023-12-31
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue   
Sales revenue$ 251,607$ 320,549$ 311,730
Rental revenue64,05356,69246,273
Total revenue315,660377,241358,003
Cost of revenue   
Cost of sales revenue158,636197,805161,824
Cost of rental revenue, including depreciation of $12,893, $11,103 and $8,860, respectively30,32525,90319,696
Total cost of revenue188,961223,708181,520
Gross profit   
Gross profit-sales revenue92,971122,744149,906
Gross profit-rental revenue33,72830,78926,577
Total gross profit126,699153,533176,483
Operating expense   
Research and development20,84021,94316,576
Sales and marketing107,091120,767112,815
General and administrative75,26043,90537,852
Loss on disposal of intangible asset 52,161 
Impairment charges32,8940 
Total operating expense236,085238,776167,243
Income (loss) from operations(109,386)(85,243)9,240
Other income (expense)   
Interest income, net6,5742,837129
Other income (expense)468(862)(710)
Total other income (expense), net7,0421,975(581)
Income (loss) before provision for income taxes(102,344)(83,268)8,659
Provision for income taxes10550414,992
Net loss(102,449)(83,772)(6,333)
Other comprehensive income (loss), net of tax   
Change in foreign currency translation adjustment1,358(597)(800)
Change in net unrealized gains (losses) on foreign currency hedging (3,130)1,746
Less: reclassification adjustment for net (gains) losses included in net loss 1,99047
Total net change in unrealized gains (losses) on foreign currency hedging (1,140)1,793
Change in net unrealized gains (losses) on marketable securities110251
Total other comprehensive income (loss), net of tax1,468(1,712)994
Comprehensive loss$ (100,981)$ (85,484)$ (5,339)
Basic net loss per share attributable to common stockholders (Note 2)$ (4.42)$ (3.67)$ (0.28)
Diluted net loss per share attributable to common stockholders (Note 2)$ (4.42)$ (3.67)$ (0.28)
Weighted-average number of shares used in calculating net loss per share attributable to common stockholders:   
Basic common shares23,176,09822,852,57122,490,027
Diluted common shares23,176,09822,852,57122,490,027

INGN Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets  
Cash and cash equivalents$ 125,492$ 187,014
Marketable securities2,979 
Accounts receivable, net42,24162,725
Inventories, net21,84034,093
Income tax receivable6691,626
Prepaid expenses and other current assets13,84619,187
Total current assets207,067304,645
Property and equipment, net50,31643,269
Goodwill10,05732,852
Intangible assets, net34,591177
Operating lease right-of-use asset20,33821,653
Other assets3,8252,445
Total assets326,194405,041
Current liabilities  
Accounts payable and accrued expenses30,14233,974
Accrued payroll11,06611,190
Warranty reserve - current9,6287,790
Operating lease liability - current3,6533,515
Earnout Liability10,000 
Deferred revenue - current7,9808,880
Income tax payable27 
Total current liabilities72,49665,349
Long-term liabilities  
Warranty reserve - noncurrent13,85012,123
Operating lease liability - noncurrent18,27019,764
Deferred revenue - noncurrent8,22710,399
Deferred tax liability8,539 
Total liabilities121,382107,635
Commitments and contingencies (Note 9)
Stockholders' equity  
Common stock, $0.001 par value per share; 200,000,000 shares authorized; 23,324,750 and 22,941,643 shares issued and outstanding as of December 31, 2023 and 2022, respectively2323
Additional paid-in capital320,513312,126
Accumulated deficit(116,949)(14,500)
Accumulated other comprehensive income (loss)1,225(243)
Total stockholders' equity204,812297,406
Total liabilities and stockholders' equity$ 326,194$ 405,041
INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; and related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
 CEO
 WEBSITEwww.inogen.com
 EMPLOYEES1026

Inogen Inc Frequently Asked Questions


What is the ticker symbol for Inogen Inc? What does INGN stand for in stocks?

INGN is the stock ticker symbol of Inogen Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Inogen Inc (INGN)?

As of Wed Mar 27 2024, market cap of Inogen Inc is 185.91 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of INGN stock?

You can check INGN's fair value in chart for subscribers.

What is the fair value of INGN stock?

You can check INGN's fair value in chart for subscribers. The fair value of Inogen Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Inogen Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for INGN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Inogen Inc a good stock to buy?

The fair value guage provides a quick view whether INGN is over valued or under valued. Whether Inogen Inc is cheap or expensive depends on the assumptions which impact Inogen Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INGN.

What is Inogen Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Mar 27 2024, INGN's PE ratio (Price to Earnings) is -1.81 and Price to Sales (PS) ratio is 0.59. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. INGN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Inogen Inc's stock?

In the past 10 years, Inogen Inc has provided -0.085 (multiply by 100 for percentage) rate of return.